Stay updated on Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial
Sign up to get notified when there's something new on the Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial page.

Latest updates to the Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a minor revision update from v3.4.1 to v3.4.2, indicating a version bump rather than substantive changes to study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous revision v3.4.0.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page, representing a minor technical update that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded a Locations section with the New York site (Icahn School of Medicine at Mount Sinai). Removed the HHS Vulnerability Disclosure and the older 'New York Locations' entry.SummaryDifference0.2%

- Check91 days agoChange DetectedUpdated the Publications section to clarify that publications are automatically filled from PubMed and may not necessarily be about the study. Added a revision tag v3.3.2.SummaryDifference0.1%

- Check99 days agoChange DetectedRemoved the government funding status notice that warned information might not be up to date and directed users to cc.nih.gov and opm.gov. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial page.